Journal article · 2026 · Open access

Clonal hematopoiesis and cytopenias following CAR19 therapy

Mark P. Hamilton, Nick A. Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio, Brian J. Sworder, Stefan Alig, Zinaida Good, Joseph G. Schroers‐Martin, John Tamaresis, Mohammad Shahrokh Esfahani, Ying Lü and 25 more

Nature Genetics, 58(11), 2895–2909 · Published 2 November 2026 · DOI 10.1038/s41588-026-02795-5

Open PDFView at the publisherCite this paper

In brief

“Clonal hematopoiesis and cytopenias following CAR19 therapy” is a 2026 journal article by Mark P. Hamilton and 36 co-authors, published in Nature Genetics. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Nature Genetics.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
2.40
References
127
Authors
37

Abstract

CD19-directed chimeric antigen receptor T cell therapy (CAR19) improves survival in relapsed/refractory large B cell lymphoma compared with immunochemotherapy with intent for autologous hematopoietic cell transplantation (autoHCT). However, major toxicities include prolonged cytopenias, infection and secondary hematologic malignancies. Here, to investigate these complications, we studied patients with lymphoma receiving CAR19 and compared clinical outcomes to propensity-matched autoHCT-treated controls. CAR19-treated patients exhibited impaired immune reconstitution and increased infection. Bone marrow analysis showed that prolonged post-CAR cytopenias are associated with clonal cytopenias of undetermined significance and interferon-mediated inflammation. Clonal hematopoiesis (CH) commonly expanded following CAR19 infusion and was associated with impaired immune reconstitution and treatment-related myeloid malignancy (tMN). Post-CAR tMN was molecularly and clinically comparable to post-autoHCT tMN. Single-cell DNA analysis revealed mostly independent CH clones, while CAR integration into CH-mutant T cells occurred frequently and may drive expansion and persistence. Together, these findings implicate CH expansion and marrow inflammation in key CAR19-associated toxicities. This study shows that clonal hematopoiesis expands after chimeric antigen receptor (CAR) T cell therapy and contributes to secondary myeloid cancers. In addition, the CAR vector frequently integrates into pre-existing clonal hematopoiesis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hamilton, M. P., Phillips, N. A., Noordenbos, T., Boegeholz, J., Sugio, T., Sworder, B. J., Alig, S., Good, Z., Schroers‐Martin, J. G., Tamaresis, J., Esfahani, M. S., Lü, Y., Olsen, M., Liu, C. L., Ehlinger, Z., Desai, M., Muffly, L. S., Negrin, R., Arai, S., . . . Alizadeh, A. A. (2026). Clonal hematopoiesis and cytopenias following CAR19 therapy. Nature Genetics, 58(11), 2895–2909. https://doi.org/10.1038/s41588-026-02795-5

MLA 9

Hamilton, Mark P., et al. “Clonal hematopoiesis and cytopenias following CAR19 therapy.” Nature Genetics, vol. 58, no. 11, 2026, pp. 2895–2909. https://doi.org/10.1038/s41588-026-02795-5.

Chicago

Hamilton, Mark P., Nick A. Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio, Brian J. Sworder, Stefan Alig, et al. 2026. “Clonal hematopoiesis and cytopenias following CAR19 therapy.” Nature Genetics 58 (11): 2895–2909. https://doi.org/10.1038/s41588-026-02795-5.

Harvard

Hamilton, M. P. et al. (2026) ‘Clonal hematopoiesis and cytopenias following CAR19 therapy’, Nature Genetics, 58(11), pp. 2895–2909. doi:10.1038/s41588-026-02795-5.

IEEE

M. P. Hamilton et al., “Clonal hematopoiesis and cytopenias following CAR19 therapy,” Nature Genetics, vol. 58, no. 11, pp. 2895–2909, 2026, doi: 10.1038/s41588-026-02795-5.

BibTeX

@article{hamilton2026clonal,
  title     = {{Clonal hematopoiesis and cytopenias following CAR19 therapy}},
  author    = {Hamilton, Mark P. and Phillips, Nick A. and Noordenbos, Troy and Boegeholz, Jan and Sugio, Takeshi and Sworder, Brian J. and Alig, Stefan and Good, Zinaida and Schroers‐Martin, Joseph G. and Tamaresis, John and Esfahani, Mohammad Shahrokh and Lü, Ying and Olsen, Mari and Liu, Chih Long and Ehlinger, Zach and Desai, Moksha and Muffly, Lori S. and Negrin, RS and Arai, Sally and Johnston, Laura and Lowsky, Robert and Meyer, Everett and Rezvani, Andrew and Shizuru, Judith A. and Weng, Wen-Kai and Shiraz, Parveen and Sidana, Surbhi and Bharadwaj, Sushma and Smith, Melody M. and Dahiya, Saurabh and others},
  journal   = {Nature Genetics},
  year      = {2026},
  volume    = {58},
  number    = {11},
  pages     = {2895--2909},
  doi       = {10.1038/s41588-026-02795-5},
  url       = {https://doi.org/10.1038/s41588-026-02795-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • clonal hematopoiesis
  • CD19 chimeric antigen receptor
  • CAR T-cell therapy
  • large B-cell lymphoma
  • cytopenia
  • immune reconstitution
  • infection
  • bone marrow inflammation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Hamilton, M. P., Phillips, N. A., Noordenbos, T., Boegeholz, J., Sugio, T., Sworder, B. J., Alig, S., Good, Z., Schroers‐Martin, J. G., Tamaresis, J., Esfahani, M. S., Lü, Y., Olsen, M., Liu, C. L., Ehlinger, Z., Desai, M., Muffly, L. S., Negrin, R., Arai, S., . . . Alizadeh, A. A. (2026). Clonal hematopoiesis and cytopenias following CAR19 therapy. Nature Genetics, 58(11), 2895–2909. https://doi.org/10.1038/s41588-026-02795-5

How many times has this paper been cited?

1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature Genetics: sign in and open the PDF from this page.

Who wrote this paper?

Mark P. Hamilton, Nick A. Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio, Brian J. Sworder, Stefan Alig, Zinaida Good, Joseph G. Schroers‐Martin, John Tamaresis, Mohammad Shahrokh Esfahani, Ying Lü and 25 more.

What is the DOI of this paper?

10.1038/s41588-026-02795-5, permanently at https://doi.org/10.1038/s41588-026-02795-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.